Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Navrogen logo — Finding cures with you in mind

Navrogen

Finding cures with you in mind

Founded 2017 United States United States 4 employees Seed Total: $6.20M Biotechnology, Life Sciences +1

General Information

Company Name Navrogen
Founded Year 2017
Location United States United States +1
Employees 4
Industries Biotechnology, Life Sciences, Pharmaceutical
Funding Stage Seed
Social

Get notified when Navrogen moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Navrogen

Navrogen Inc. is a biopharmaceutical company founded in 2017 with the slogan "Finding cures with you in mind." The company is headquartered in the United States and operates within the Biotechnology and Pharmaceutical industries. Navrogen's focus is on the targeted treatment of cancer, specifically enhancing the immune system to combat the disease. They are dedicated to removing factors produced or induced by tumor cells, which inhibit the cancer-fighting immune system. In their latest funding round at 09 August 2021, Navrogen secured a $3.00M investment from Tellus BioVentures. This capital injection will likely support the company's continued research and development efforts. Navrogen's innovative approach to cancer treatment and their ability to attract investment from reputable firms such as Tellus BioVentures positions them as an intriguing prospect in the biopharmaceutical sector.

Taxonomy: biopharmaceuticals, targeted therapies, oncology, immuno oncology, cancer treatment, immune system modulation

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round •••••• 1
Investor
09 Aug 2021
Convertible Note •••••• 1
Investor
17 Sep 2019

Navrogen Alternatives & Competitors

Navrogen vs
Apexigen
Apexigen United States

Creating Transformative Immunotherapies for Patients with Cancer

Post Ipo Equity
11 employees
Biopharma, Biotechnology
Navrogen vs
NeoPhore Ltd
NeoPhore Ltd United Kingdom

Discovering drugs that create neoantigens

Series B
18 employees
Biotechnology, Health and Wellness
Navrogen vs
Umoja Biopharma
Umoja Biopharma

Pioneering advanced immunotherapies to empower the body's innate ability to fight cancer by reengine...

Series C
9 employees
Biopharma, Biotechnology

FAQ About Navrogen

Finding cures with you in mind
Navrogen was founded in 2017.
Navrogen is headquartered in United States.
Navrogen operates in the following industries: Biotechnology, Life Sciences, Pharmaceutical.
Navrogen has approximately 4 employees.
Navrogen has completed 2 funding rounds, raising a total of $6.20M. The latest funding stage is Seed.
Top alternatives and competitors to Navrogen include Apexigen, NeoPhore Ltd, Umoja Biopharma, Oncofactor Corporation, Denvax . These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Navrogen and Apexigen are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Navrogen and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy